Thermo Fisher Scientific (TMO) Net Cash Flow (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Net Cash Flow for 18 consecutive years, with $718.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow rose 498.33% year-over-year to $718.0 million; the trailing twelve-month figure through Jun 2026 stood at -$600.0 million (up 78.13% YoY), and the FY2025 full-year result was $5.6 billion, up 240.49% from the prior year.
• Net Cash Flow climbed to $718.0 million in Q2 2026 per TMO's latest filing, from -$6.7 billion in the prior quarter.
• Across five years, Net Cash Flow topped out at $7.9 billion in Q4 2025 and bottomed at -$6.7 billion in Q1 2026.
• Historically, Net Cash Flow has averaged -$29.2 million across 5 years, with a median of -$131.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Net Cash Flow soared 2311.8% in 2025, then slumped 7202.13% in 2026.
• Over 5 years, Net Cash Flow stood at $5.4 billion in 2022, then slumped by 64.15% to $1.9 billion in 2023, then sank by 118.55% to -$356.0 million in 2024, then jumped by 2311.8% to $7.9 billion in 2025, then sank by 90.88% to $718.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $718.0 million, -$6.7 billion, and $7.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.